Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
KTTAW | US
-0.00
-13.64%
Healthcare
Biotechnology
30/06/2024
23/04/2026
0.01
0.01
0.01
0.01
Low Market Beta (-0.4 to 0.8)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
237.7%1 month
1900.3%3 months
1571.7%6 months
818.3%-
-
-
-
-
-
-
-
-16.27M
-
-
-
-
-
-
-63.25
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.01
Range1M
0.01
Range3M
0.01
Rel. volume
1.69
Price X volume
278.81
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CURE Pharmaceutical Holding Corp | CURR | Drug Manufacturers-Specialty & Generic | 3.19 | 0 | 0.63% | n/a | |
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.54 | 0 | 0.08% | 25.57 | 121.93% |
| Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 4.3 | 0 | -12.51% | n/a | 5.40% |
| Rocket Pharmaceuticals Inc. Warrant | RCKTW | Biotechnology | 0.01 | 0 | 0.00% | n/a | 0.00% |
| Nutriband Inc. Warrant | NTRBW | Biotechnology | 1.2 | 0 | n/a | 1.72% | |
| ICUCW | ICUCW | Biotechnology | 0.0199 | 0 | -0.50% | n/a | -45.50% |
| Humacyte Inc | HUMAW | Biotechnology | 0.0881 | 0 | -11.55% | n/a | -63.37% |
| EyeGate Pharmaceuticals Inc | EYEG | Biotechnology | 35.4835 | 0 | -0.29% | n/a | |
| COEPW | COEPW | Biotechnology | 0.0092 | 0 | -16.36% | n/a | 25.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 0.53 | - |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 1,571.74 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | - | 3.66B | - |